Recent artificial intelligence (AI) advancements in cardiovascular care offer potential
enhancements in diagnosis, treatment, and outcomes. Innovations to date focus on …

Recent advances in machine learning (ML) have made it possible to analyze high-
dimensional and complex data—such as free text, images, waveforms, videos, and sound …

The coronary angiogram is the gold standard for evaluating the severity of coronary artery
disease stenoses. Presently, the assessment is conducted visually by cardiologists, a …

About 380 thousand people in the United States die each year because of coronary artery
disease. About 2 in 10 deaths from CAD happen in adults less than 65 years old. Early …

Randomized clinical trials are the gold standard for establishing the efficacy and safety of
cardiovascular therapies. However, current pivotal trials are expensive, lengthy, and …

Driven by recent innovations and technological progress, the increasing quality and amount
of biomedical data coupled with the advances in computing power allowed for much …

Cardiovascular diseases are the leading cause of death globally and contribute significantly
to the cost of healthcare. Artificial intelligence (AI) is poised to reshape cardiology. Using …

Aims Coronary artery disease (CAD) is a highly prevalent disease with modifiable risk
factors. In patients with suspected obstructive CAD, evaluating the pre-test probability model …

Bias in health care has been well documented and results in disparate and worsened
outcomes for at-risk groups. Medical imaging plays a critical role in facilitating patient …

Research in artificial intelligence (AI) has progressed over the past decade. The field of
cardiac imaging has seen significant developments using newly developed deep learning …